One of the biggest wealth-creating events in history is coming, and this will be the catalyst that sets it off…

A 5X leap from here.

That’s how much a listing on the New York Stock Exchange (NYSE) or Nasdaq could be worth to Trulieve Cannabis Corp. (OTC: TCNNF).

Last week I showed you why.

The NYSE and Nasdaq are the largest and most liquid exchanges in the world.

And even though Trulieve and many of the other top multistate operators (MSOs) easily meet the criteria to list their stocks – with multibillion-dollar market caps supported by revenues expected to approach, and even exceed, the billion-dollar mark this year – cannabis’s federally illegal status has kept them locked out.

But not for long.

Congress is hard at work breaking down barriers to cannabis – one of which will inevitably clear the path to MSOs listing on the NYSE and Nasdaq.

Once this last barrier is cast aside, which could happen at any time, you can bet there will be a mad rush of up-listings as Trulieve, Curaleaf Holdings Inc. (OTC: CURLF), and many other top MSOs race to list their shares on the biggest money stage in the world.

Gaining access to the massive trading volume that flows through these exchanges will trigger one of the biggest millionaire-making events in history – and by investing in the right cannabis stocks today, you’ll be standing at the forefront.

Here’s what you need to know to make sure you’re ready to take full advantage of the profits at stake…

Getting Big Money’s Attention

Now, for a company’s stock price to reach its full potential, the company needs eyeballs – and lots of them.

By that, I mean it needs the attention of the entire market. I’m talking as many market players as possible, which includes individual investors, advisors, fund managers, brokers, and professional analysts.

After all, stock prices don’t move on their own. It takes a buyer and a seller transacting to determine a price. For that stock price to reflect everything that’s going on with a company, it needs hundreds of thousands – even millions – of shares changing hands per day.

Now, every single one of those market players pays attention to a company’s stock because they have money to put to work. Some have hundreds of dollars to invest…others have billions.

And when a stock trades millions of shares each day, you can bet it has Big Money’s attention.

“Big Money” refers to institutional investors such as pension plans, mutual fund managers, foundations and endowments, and wealth advisors from around the world. You can learn more about those players and their impact on the markets right here.

But to attract that money-motivated attention, a company’s stock needs a big stage.

And the biggest stages in the world are right here in the U.S. at the NYSE and Nasdaq.

The Unmatched Trading Power of the NYSE and Nasdaq

Look at how much these two exchanges dominate stock trading around the world.

Source: National Institute for Cannabis Investors

For reference, the total value of all stocks traded globally exceeds $97 trillion per year. Of that, $53 trillion trades on U.S. stock markets.

That’s nearly 55% of all public stock trading around the world. No other country comes close.

The next largest exchange-traded markets can be found in Japan, but those only account for a mere $1.3 trillion, or a little more than 1% of the total.

So, it’s clear that the U.S. has a commanding share of global stock markets.

And within the U.S., almost all that value trades on the New York Stock Exchange and Nasdaq.

Nearly 90%, in fact.

Source: National Institute for Cannabis Investors

Companies that can’t access the 90% – but instead are relegated to the over-the-counter markets (OTCMKTs) – can’t grab Big Money’s attention.

And with those eyeballs locked out, even stocks of hyper-growth companies like Trulieve cannot realize their full potential.

The Clock Is Ticking

But they won’t stay locked out for long.

The pressure to legalize cannabis at the federal level is building each day.

Leading members of the Senate have declared cannabis legislation a priority. The U.S. House of Representatives just reintroduced the Marijuana Opportunity Reinvestment and Expungement (MORE) Act for a vote, a bill originally sponsored by now-Vice President Kamala Harris (D-CA).

And the private sector is getting into the act, as evidenced by the fact that Amazon will no longer test for marijuana use among its employees.

Now, you don’t want to wait for the path to clear before buying stocks in Trulieve, Curaleaf, and other top MSOs that will be among the first to up-list their stocks.

Waiting for the final shoe to drop is a sure-fire way to miss the boat. Those who wait will have to compete with all the other Big Money investors for increasingly higher-priced shares.

And while those Big Money players have no choice but to wait for these stocks to hit the NYSE and Nasdaq, as an individual retail investor, you have the unique opportunity to invest now – before these cannabis stocks up-list and send share prices surging.

Today, you just need to know where to put your money for the biggest potential returns…and that’s what we help you do with NICI Membership.

We tell you exactly which stocks to buy and when with real-time trade recommendations and profit alerts – and we give you all the resources you need to make the most money possible from cannabis investing.

So, don’t wait. Help secure your financial future by joining NICI Membership today.

Simply click here to get started.

Take care,

Don Yocham
Executive Director, National Institute for Cannabis Investors


16 responses to “This Coming Catalyst Will Trigger One of the Biggest Wealth-Creating Events in History – And You’re Already Standing at the Forefront”

  1. This is what I have been waiting for. Have been building a large list of Marijuna stocks for a number of years. .The sooner the better. Bring them on.

  2. its all sound good but we are still 2 to 3 years away Joe Biden is the problem and he has put his V.P in check . Look at Washington D.C Law still waiting after years for legal sales .

    • How can you say Joe Biden is the problem when the first year he’s president we’ve seen astronomical cannabis legalizations among the states… Biden and Harris are pro cannabis.

    • Hi Edgardo,

      The NYSE and Nasdaq would need something like the MORE Act or SAFE Banking Act to pass in order to feel comfortable listing U.S. cannabis stocks. Remember that cannabis is still federally illegal, and the U.S. exchanges don’t want to take the risk of listing a business that is operating against federal law. But there is a lot of positive momentum out there for something to pass.

  3. Hey Don how are you? You continue to impress me with how you stay on top of things. You speak about the companies in our portfolio good or bad in a timely fashion. You support your recommendation with facts based on actual data. You have been simply remarkable and straight forward with your analysis of the industry and the companies you have us investing in since the day you took over this operation!!! I want you to know that I am blessed to have you in my corner for encouragement and support and NICI should be glad to have you too!!! I hope you and your family have a safe and enjoyable evening!!!!

  4. I paid for another year of Subscription and I am very happy to be a member. I need to know how can I access the latest news and updates on what’s happening when there is no log in on the NICI website.

      • Yes, I agree… Although that may not happen but since majority of both Democrats and Republicans are starting to be pro cannabis we will hopefully get cannabis legalized on a federal level 2021/2022…..

    • Hi Elisa,

      On the NICI homepage, there is a Log In button in the upper right corner –

      If you have any trouble accessing it, our Customer Service department would be more than happy to help you.

      You can contact them at 1-866-260-0361.


  6. Hey Don,
    I’m a little confused about your opening statement? I already own shares of Jushi which I bought last Fall and I’ll soon be investing in shares of Trulieve both of which are listed on the Nasdaq Composite, but not the NYSE.
    Would you care to enlighten me on this topic?
    Perhaps I’m not ‘in the know’ enough to understand your earlier statement of these and many other MSO’s rushing to list on the NYSE and NASDAQ?
    Many, certainly not all, cannabis companies are listed on the NASDAQ composite today and it definitely would be a potentially huge boon to their overall stock value if regulators allowed them to list on the NYSE as well and that is what I think everyone is waiting for later this year, or more certainly next year.
    Good luck to all who do invest and choose well when you do!
    james g.

    • Hi James,

      Because cannabis is illegal at the federal level, Trulieve and Jushi do not trade on U.S. exchanges like the Nasdaq or NYSE.

      U.S. companies would like to list on U.S. exchanges, but they currently have to list on Canadian exchanges or on over-the-counter markets (OTCMKTs).

      It will certainly be a boon when these companies can start listing on U.S. exchanges, a lot more money will start flowing into the sector.

Leave a Reply

Your email address will not be published. Required fields are marked *